tiprankstipranks
Trending News
More News >
Statera BioPharma (STAB)
OTHER OTC:STAB
US Market

Statera BioPharma (STAB) Income Statement

Compare
190 Followers

Statera BioPharma Income Statement

Last quarter (Q3 2022), Statera BioPharma's total revenue was $670.47K, an increase of 183.48% from the same quarter last year. In Q3, Statera BioPharma's net income was $-5.16M. See Statera BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -488.31K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 28.83M$ 10.50M$ 2.81M$ 5.94M$ 7.55M
Depreciation and Amortization
$ 255.57K$ 947.00$ 13.78K$ 18.18K$ 21.08K
EBITDA
$ -170.65M$ -10.96M$ -3.09M$ -4.80M$ -5.60M
Operating Income
$ -98.34M$ -10.50M$ -2.81M$ -4.80M$ -5.60M
Other Income/Expenses
$ -3.53M$ -1.59M$ -409.85K$ 1.19M$ -4.11M
Pretax Income
$ -101.88M$ -12.09M$ -3.22M$ -3.61M$ -9.71M
Net Income
$ -174.41M$ -13.22M$ -3.35M$ -3.61M$ -9.71M
Per Share Metrics
Basic EPS
$ -4.97$ -0.52$ -0.13$ -0.32$ -0.87
Diluted EPS
$ -4.97$ -0.52$ -0.13$ -0.32$ -0.87
Weighted Average Shares Outstanding
35.11M 25.65M 25.65M 11.29M 11.19M
Weighted Average Shares Outstanding (Diluted)
35.11M 25.65M 25.65M 11.29M 11.19M
Currency in USD

Statera BioPharma Earnings and Revenue History